Latest News

Think Outside the Lung to COPD Comorbidities ©BasArtYa/stock.adobe.com
Comorbidities Associated with COPD Affect Outcomes, Require Attention

May 26th 2023

At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.

Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Study  lungs ©pascalkphoto/stock.adobe.com
Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Trial

May 22nd 2023

COPD Increases Risk for Heart Failure in People who Experience AMI ©tashatuvango/Adobe Stock
COPD Increases Risk for Heart Failure in People who Experience AMI

May 18th 2023

Pneumococcal Vaccines for Adults: The Devil is Still in the Details image of pneumococcus virus ©RoyaltyStockPhoto/shutterstock.com
Pneumococcal Vaccines for Adults: The Devil is Still in the Details

May 8th 2023

RSV Infection During Infancy Linked to Higher Risk of Asthma in Childhood
RSV Infection During Infancy Linked to Higher Risk of Asthma in Childhood

April 25th 2023

Latest CME Events & Activities

Virtual Tumor Board®: Multidisciplinary Approaches to Treating Cancer-related LEMS

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Trekking Through the Latest Updates for ROS1-Targeted Therapies

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

View More

Navigating the Latest Data on NTRK-Targeted Therapies

View More

Community Practice Connections™: 17th Annual New York Lung Cancers Symposium

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

View More

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

Advancing Precision Care Through Biomarker-Driven Therapy: CEACAM5 as a Therapeutic Target in NSCLC

View More

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More

Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal Is Cure?

View More

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

View More

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

View More

Expert Illustrations & Commentaries™: Exploring the Clinical Rationale for Antagonizing Inflammatory IL-1-beta Signaling in NSCLC

View More

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated With Treatment

View More

Patient, Provider, and Caregiver Connection™: Shedding a Light on the Patient Journey with KRAS Mutated Lung Cancer

View More

Clinical Vignettes®: Multidisciplinary Discussions on the Application of Novel EGFR Exon 20 Targeted Regimens for NSCLC Management

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Antibody-Drug Conjugates in Advanced NSCLC

View More

Advances In™ NSCLC: Exploring CEACAM5 As A New Therapeutic Target

View More

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

View More

Community Practice Connections™: Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

View More

Advances In™: The Role of NRG1 Fusions Across Tumor Types

View More

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

View More

Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

View More

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

View More

More News

© 2023 MJH Life Sciences

All rights reserved.